44th Annual Cowen Healthcare Conference on March 4
Leerink Partners Global Biopharma Conference on March 12
Barclays 26th Annual Global Healthcare Conference on March 13
NOVATO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced that management will be participating in three upcoming investor conferences.
44th Annual Cowen Healthcare Conference (Boston, MA)
- Monday, March 4, 2024, Eric Crombez, M.D., Chief Medical Officer, will participate in ...